Pauline Merrill to Adalimumab
This is a "connection" page, showing publications Pauline Merrill has written about Adalimumab.
Connection Strength
1.037
-
Efficacy of Adalimumab in Non-Infectious Uveitis Across Different Etiologies: A Post Hoc Analysis of the VISUAL I and VISUAL II Trials. Ocul Immunol Inflamm. 2021 Nov 17; 29(7-8):1569-1575.
Score: 0.715
-
Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis. Ophthalmology. 2021 06; 128(6):899-909.
Score: 0.184
-
Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. 2016 Sep 17; 388(10050):1183-92.
Score: 0.138